{"SLR NAME":"A meta-analysis of corticosteroids for COVID-19 treatment","References":[{"title1":"Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Estimates of the severity of coronavirus disease 2019: a model-based analysis.","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report:43"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Assessing the severity of the novel influenza A/H1N1 pandemic"},{"title3":"Potential biases in estimating absolute and relative case-fatality risks during outbreaks"},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases"},{"title3":"Early epidemiological assessment of the transmission potential and virulence of 2019 novel coronavirus in Wuhan City: China, January-February, 2020"},{"title3":"2019-nCoV: preliminary estimates of the confirmed-case-fatality-ratio and infection-fatality-ratio, and initial pandemic risk assessment"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Ministry of Health, Labour and Welfare"},{"title3":"China statistical yearbook"},{"title3":"drjacoby"},{"title3":"CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease. Boston College of Economics"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Estimating the severity and subclinical burden of middle east respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia"},{"title3":"Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study"},{"title3":"Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1"},{"title3":"Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China.","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","References":[]},{"title2":"Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","References":[{"title3":"WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"title3":"WHO. WHO coronavirus disease 2019 (covid-19) situation report-101. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2."},{"title3":"The UK's pandemic influenza research portfolio: a model for future research on emerging infections"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection"},{"title3":"WHO. WHO preliminary clinical description of severe acute respiratory syndrome. 2003.https://www.who.int/csr/sars/clinical/en/."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area"},{"title3":"Clarification of mortality rate and data in abstract, results, and table 2"},{"title3":"Conolly A, Craig S. Health survey for England 2018: overweight and obesity in adults and children. 2019. https://files.digital.nhs.uk/52/FD7E18/HSE18-Adult-Child-Obesity-rep.pdf."},{"title3":"Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK"},{"title3":"Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)"},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Host susceptibility to severe influenza A virus infection"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"ICNARC. ICNARC report on COVID-19 in critical care. 2020:1-9. https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports."},{"title3":"ISARIC4C. ISARIC Coronavirus Clinical Characterisation Consortium. 2020. https://isaric4c.net/."},{"title3":"GOV.UK. New and Emerging Respiratory Virus Threats Advisory Group. 2020. https://www.gov.uk/government/groups/new-and-emerging-respiratory-virus-threats-advisory-group."},{"title3":"GOV.UK. Scientific Advisory Group for Emergencies. 2020. https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response."},{"title3":"GOV.UK. Scientific Pandemic Influenza Group on Modelling. 2020. https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling."}]},{"title2":"Remdesivir for the treatment of Covid-19 : preliminary report.","References":[]},{"title2":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.","References":[{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 autopsies, Oklahoma, USA"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer"},{"title3":"Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection:Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Megakaryocytes and platelet homeostasis in diffuse alveolar damage"},{"title3":"The intracellular sites of early replication and budding of SARS-coronavirus"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Anticoagulant therapy in acute respiratory distress syndrome"},{"title3":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action"},{"title3":"SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology"}]},{"title2":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"Influenza : time to target the host?","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Cytokine release syndrome in severe COVID-19.","References":[{"title3":"Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis"},{"title3":"Viral RNA Load in Plasma Is Associated with Critical Illness and a Dysregulated Host Response in COVID-19"},{"title3":"Endotoxin and Cytokine Reducing Properties of the oXiris Membrane in Patients with Septic Shock: A Randomized Crossover Double-Blind Study"},{"title3":"Extracorporeal Immune Modulation in COVID-19 Induced Immune Dysfunction and Secondary Infections: the Role of oXiris  Membrane"},{"title3":"Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital"},{"title3":"Is There a Role for Blood Purification Therapies Targeting Cytokine Storm Syndrome in Critically Severe COVID-19 Patients?"},{"title3":"Continuous Renal Replacement Therapy in Cytokine Release Syndrome Following Immunotherapy or Cellular Therapies?"},{"title3":"The Role of IL-6 and Other Mediators in the Cytokine Storm Associated with SARS-CoV-2 Infection"},{"title3":"Efficacy of Continuous Renal Replacement Therapy in the Treatment of Severe Acute Pancreatitis Associated Acute Respiratory Distress Syndrome"},{"title3":"An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival"},{"title3":"Changes of Serum Procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High Mobility Group Protein-B1 (HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy (CRRT) and Its Clinical Significance"},{"title3":"A Multi-center Cross-Sectional Study on Blood Purification Among Adult Patients in Intensive Care Unit in China: a Study Protocol"},{"title3":"Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19"},{"title3":"Vaccine Breakthrough Infections with SARS-CoV-2 Variants"},{"title3":"6-month Consequences of COVID-19 in Patients Discharged from Hospital: a Cohort Study"},{"title3":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China"},{"title3":"Coronavirus Disease 2019 (COVID-19): Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome"},{"title3":"Low-to-moderate Dose Corticosteroids Treatment in Hospitalized Adults with COVID-19"},{"title3":"Clearance of Inflammatory Cytokines in Patients with Septic Acute Kidney Injury during Renal Replacement Therapy Using the EMiC2 Filter (Clic-AKI Study)"},{"title3":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression"},{"title3":"Extracorporeal Blood Purification Therapies for Sepsis"},{"title3":"COVID-19: What Type of Cytokine Storm Are We Dealing with?"},{"title3":"Efficacy and Safety of the Monoclonal Anti-tumor Necrosis Factor Antibody F(ab')2 Fragment Afelimomab in Patients with Severe Sepsis and Elevated Interleukin-6 Levels"},{"title3":"High-Dose versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial"},{"title3":"The Deregulated Immune Reaction and Cytokines Release Storm (CRS) in COVID-19 Disease"},{"title3":"Removal of Inflammatory Cytokines and Endotoxin by Veno-Venous Continuous Renal Replacement Therapy for Burned Patients with Sepsis"},{"title3":"Extracorporeal Blood Purification Is Associated with Improvement in Biochemical and Clinical Variables in the Critically-Ill COVID-19 Patients"},{"title3":"Factors Leading to High Morbidity and Mortality of COVID-19 in Patients with Type 2 Diabetes"},{"title3":"Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study"},{"title3":"Continuous Renal Replacement Therapy with oXiris  Membrane in Severe Ebstein-Barr Virus-Mediated Hemophagocytic Lymphohistiocytosis: A Case Report"},{"title3":"oXiris  Use in Septic Shock: Experience of Two French Centres"},{"title3":"Effects of Acute Kidney Injury on Acute Pancreatitis Patients' Survival Rate in Intensive Care Unit: A Retrospective Study"},{"title3":"Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19"},{"title3":"Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series"},{"title3":"Corticosteroid Use in COVID-19 Patients: a Systematic Review and Meta-Analysis on Clinical Outcomes"},{"title3":"Blood Purification Therapy with a Hemodiafilter Featuring Enhanced Adsorptive Properties for Cytokine Removal in Patients Presenting COVID-19: a Pilot Study"},{"title3":"Cytokine Levels in Sputum, Not Serum, May Be More Helpful for Indicating the Damage in the Lung and the Prognosis of Severe COVID-19 - A Case Series"},{"title3":"The Effectiveness of Continuous Renal Replacement Therapy in Critical COVID-19 Patients with Cytokine Release Syndrome: a Retrospective, Multicenter, Descriptive Study from Wuhan, China"},{"title3":"Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: a Single-Centered, Retrospective, Observational Study"},{"title3":"The Therapeutic Effect of High-Volume Hemofiltration on Sepsis: a Systematic Review and Meta-Analysis"},{"title3":"Association of Inflammatory Markers with the Severity of COVID-19: A Meta-Analysis"},{"title3":"The Absorbing Filter Oxiris in Severe Coronavirus Disease 2019 Patients: A Case Series"}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia.","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.","References":[]},{"title2":"GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia.","References":[]},{"title2":"Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.","References":[]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.","References":[]},{"title2":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.","References":[]},{"title2":"Why do we need some large, simple randomized trials?","References":[]},{"title2":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.","References":[]},{"title2":"The magic of randomization versus the myth of real-world evidence.","References":[]},{"title2":"Modernising epidemic science: enabling patient-centred research during epidemics.","References":[{"title3":"Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec. 2016;91(11):133-43. PMID: 27766828."},{"title3":"Commission on a Global Health Risk Framework for the Future. The neglected dimension of global health security: a framework to counter infectious disease crises. 2016. https://nam.edu/wp-content/uploads/2016/01/Neglected-Dimension-of-Global-Security.pdf. Accessed 13 Nov 2016."},{"title3":"Global rise in human infectious disease outbreaks"},{"title3":"Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient"},{"title3":"Mortality after fluid bolus in African children with severe infection"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials"},{"title3":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments"},{"title3":"Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"MEPs criticise WHO over H1N1 pandemic advice"},{"title3":"Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis"},{"title3":"Ebola virus disease in West Africa--the first 9 months"},{"title3":"West African Ebola epidemic after one year--slowing but not yet under control"},{"title3":"World Health Organization. Case defintion recommendations for Ebola or Marburg virus diseases, 2014. http://apps.who.int/iris/bitstream/10665/146397/1/WHO_EVD_CaseDef_14.1_eng.pdf?ua=1&amp;ua=1. Accessed 13 Nov 2016."},{"title3":"Centers for Disease Control and Prevention. Case definition for Ebola Virus Disease (EVD), 2014. http://www.cdc.gov/vhf/ebola/healthcare-us/evaluating-patients/case-definition.html. Accessed 13 Nov 2016."},{"title3":"Molecular evidence of sexual transmission of Ebola virus"},{"title3":"Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016"},{"title3":"World Health Organization. Ethics in epidemics, emergencies and disasters: research, surveillance and patient care. http://apps.who.int/iris/bitstream/10665/196326/1/9789241549349_eng.pdf 2015. Accessed 13 Nov 2016."},{"title3":"Changing patterns of in-hospital deaths following implementation of damage control resuscitation practices in US forward military treatment facilities"},{"title3":"Thirteen survivors of prehospital thoracotomy for penetrating trauma: a prehospital physician-performed resuscitation procedure that can yield good results"},{"title3":"Advanced life support for out-of-hospital respiratory distress"},{"title3":"Evaluating clinical trial designs for investigational treatments of ebola virus disease"},{"title3":"The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola"},{"title3":"The European Rare Diseases Therapeutic Initiative"},{"title3":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/. Accessed 13 Nov 2016."},{"title3":"World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2016, 2016. http://www.who.int/influenza/human_animal_interface/EN_GIP_20160404cumulativenumberH5N1cases.pdf?ua=1. Accessed 13 Nov 2016."},{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV), 2016. http://www.who.int/emergencies/mers-cov/en/. Accessed 13 Nov 2016."},{"title3":"The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands"},{"title3":"World Health Organization. Emerging disease surveillance and response - Avian Influenza Weekly Update Number 551, 2016. http://www.wpro.who.int/emerging_diseases/AvianInfluenza/en/. Accessed 13 Nov 2016."},{"title3":"Open source clinical science for emerging infections"},{"title3":"Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)"},{"title3":"Global participation in core data sets for emerging pathogens"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians"},{"title3":"Senga M, Arabi YM, Fowler RA. Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV). J Infect Public Health. 2016. Epub ahead of print. doi:10.1016/j.jiph.2016.04.008."},{"title3":"The search for therapeutic options for Middle East Respiratory Syndrome (MERS)"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Experimental treatment of Ebola virus disease with brincidofovir"},{"title3":"Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial"},{"title3":"Evaluation of convalescent plasma for Ebola virus disease in Guinea"},{"title3":"Antiviral combinations for severe influenza"}]},{"title2":"SARS: systematic review of treatment effects.","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis.","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza.","References":[]},{"title2":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome.","References":[{"title3":"Severe acute respiratory syndrome (SARS): multi-country outbreak:update 34"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"}]},{"title2":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Consistent detection of 2019 novel coronavirus in saliva"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study"},{"title3":"Additional molecular testing of saliva specimens improves the detection of respiratory viruses"},{"title3":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens"},{"title3":"Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia"},{"title3":"Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains"},{"title3":"Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial"},{"title3":"Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus"},{"title3":"Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis"},{"title3":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Viral dynamics in asymptomatic patients with COVID-19.","References":[{"title3":"Transmission characteristics of SARS-CoV-2 that hinder effective control"},{"title3":"Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection"},{"title3":"The proportion of SARS-CoV-2 infections that are asymptomatic"},{"title3":"Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: A retrospective observational study"},{"title3":"Timelines of infection and disease in human influenza: A review of volunteer challenge studies"},{"title3":"Analysis of asymptomatic and presymtomatic transmission in SARS-CoV-2 outbreak, Germany, 2020"},{"title3":"Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2"},{"title3":"SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease"},{"title3":"Virological assessment of hospitalized patients with COVID-2019"},{"title3":"Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing"},{"title3":"Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19"},{"title3":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid"},{"title3":"Relations among questionnaire and laboratory measures of rhinovirus infection"},{"title3":"Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infection"},{"title3":"COVID-19 variant surveillance in the Republic of Korea"}]},{"title2":"Temporal dynamics in viral shedding and transmissibility of COVID-19.","References":[]},{"title2":"Virological assessment of hospitalized patients with COVID-2019.","References":[]}]}]}